Hohl Benjamin Insider Trading Activity
Hohl Benjamin has been net-selling over the last 12 months with 0 purchases and 10 sales across 1 company.
ELVN is the most-traded position with 10 trades. The largest single transaction was a sale of ELVN for $296K on Mar 6, 2026.
Performance Scorecard
Forward stock performance after each transaction by Hohl Benjamin. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.7% | 50% | 10 |
| 90 days | — | +1.6% | 50% | 10 |
| 120 days | — | -7.4% | 40% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersELVN · Enliven Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Hohl Benjamin bought and sold ELVN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 17, 2026 | ELVN | Sell | 324 | $49.97 | $16K | −0.6% | CFO | |
Jul 17, 2026 | ELVN | Sell | 123 | $53.87 | $7K | −0.3% | CFO | |
Jul 17, 2026 | ELVN | Sell | 2,638 | $53.38 | $141K | −5.4% | CFO | |
Jul 17, 2026 | ELVN | Sell | 2,564 | $52.32 | $134K | −5.0% | CFO | |
Jul 17, 2026 | ELVN | Sell | 369 | $51.48 | $19K | −0.7% | CFO | |
Mar 6, 2026 | ELVN | Sell | 10,000 | $29.58 | $296K | −16.4% | CFO | |
Sep 29, 2025 | ELVN | Sell | 3,250 | $20.40 | $66K | −12.4% | CFO | |
Aug 27, 2025 | ELVN | Sell | 3,250 | $20.63 | $67K | −12.4% | CFO | |
Jul 28, 2025 | ELVN | Sell | 65 | $21.30 | $1K | −0.3% | CFO | |
Jul 28, 2025 | ELVN | Sell | 3,185 | $20.45 | $65K | −12.1% | CFO | |
Jul 10, 2025 | ELVN | Sell | 1,000 | $22.66 | $23K | −4.2% | CFO | |
Jun 27, 2025 | ELVN | Sell | 3,052 | $20.86 | $64K | −11.6% | CFO | |
Jun 27, 2025 | ELVN | Sell | 198 | $21.66 | $4K | −0.9% | CFO | |
Jun 13, 2025 | ELVN | Sell | 3,000 | $22.55 | $68K | −11.5% | CFO | |
May 27, 2025 | ELVN | Sell | 3,250 | $16.18 | $53K | −12.4% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 15 | $1.0M |
Other insiders at Enliven Therapeutics, Inc.
5 other tracked filers at ELVN.